![Max M. Søgaard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Max M. Søgaard
Hoofd Techniek/Wetenschap/O&O bij
EXPRES2ION BIOTECH HOLDING AB
Profiel
Max M.
Søgaard currently works at Expres2ion Biotech Holding AB, as Chief Scientific Officer from 2025.
Dr. Søgaard received his graduate degree from the University of Aarhus and doctorate degree from University College London.
Actieve functies van Max M. Søgaard
| Bedrijven | Functie | Begin |
|---|---|---|
| EXPRES2ION BIOTECH HOLDING AB | Hoofd Techniek/Wetenschap/O&O | 01-01-2020 |
Opleiding van Max M. Søgaard
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
8
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Aarhus
 University of Aarhus Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University College London
 University College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Expres2ion Biotech Holding AB
 Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer | Health Technology |
